Blog
Research summaries about peptides with links to the original scientific publications.
Retatrutide: Triple-Receptor Agonism and the Phase 2 Evidence
Retatrutide (LY3437943) is an investigational peptide engineered to activate GIP, GLP-1 and glucagon receptors. This combination is being studied as a way…
Read more →
CJC-1295: Pharmacokinetics and the GH/IGF-1 Axis
CJC-1295 is a synthetic analogue of growth-hormone-releasing hormone (GHRH). Its evidence is often discussed without distinguishing long-acting DAC-conjugated CJC-1295 from shorter-acting material…
Read more →
GHK-Cu: Copper Binding, Collagen Research and Wound Models
GHK-Cu is the copper(II) complex of the naturally occurring tripeptide glycyl-L-histidyl-L-lysine. It is studied in extracellular-matrix, cell-migration and tissue-remodelling systems.Biological context and…
Read more →
BPC-157: What Tendon and Ligament Models Actually Show
BPC-157 is a 15-amino-acid research peptide associated with a body of Croatian preclinical work. Online summaries frequently describe animal results as proven…
Read more →
Tesamorelin: GHRH Signalling and Visceral-Fat Evidence
Tesamorelin is a GHRH analogue with clinical evidence in a narrowly defined population: adults with HIV-associated excess abdominal fat. That context is…
Read more →
Ipamorelin: Selective GH Secretagogue Pharmacology
Ipamorelin is a synthetic pentapeptide growth-hormone secretagogue. It works through the ghrelin/GHS receptor pathway and should not be described as interchangeable with…
Read more →
NAD+: Cellular Metabolism, Ageing Biology and Human Precursor Trials
NAD+ is an essential redox cofactor and enzyme substrate found throughout cellular metabolism. Research interest has grown around age-related changes in NAD…
Read more →
Melanotan II: Melanocortin Pharmacology and Early Human Evidence
Melanotan II is a cyclic alpha-MSH analogue that activates several melanocortin receptors. It is unapproved, and its modern human evidence base is…
Read more →
Tirzepatide: Dual GIP/GLP-1 Receptor Agonism and Clinical Trials
Tirzepatide is a dual GIP/GLP-1 receptor agonist studied in large pharmaceutical clinical programmes. Evidence for the regulated medicine does not validate the…
Read more →Information is provided for educational and research purposes only. It is not medical advice.